Literature DB >> 11195738

Iris neovascularization after vitrectomy combined with phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy.

K Kadonosono1, S Matsumoto, E Uchio, M Sugita, J Akura, S Ohno.   

Abstract

PURPOSE: To analyze the incidence of iris neovascularization after vitrectomy combined with phacoemulsification and intraocular lens (IOL) implantation using a small incision in the treatment of proliferative diabetic retinopathy (PDR). PATIENTS AND METHODS: We studied a consecutive series of 46 eyes in which vitrectomy combined with phacoemulsification and IOL implantation had been performed, and compared the surgical results with a prior series of 40 eyes in which vitrectomy alone had been performed.
RESULTS: Postoperative iris and angle neovascularization was found in 6 eyes (15%) treated by vitrectomy alone, but in only 1 eye (2%) treated by combined vitrectomy (P<0.05). Final visual acuity improved by two or more lines in 23 eyes (57%) in the vitrectomy alone group, and in 35 eyes (76%) in the combined vitrectomy group.
CONCLUSIONS: The incidence of postoperative rubeosis iridis was significantly lower, and the visual results were satisfactory with vitrectomy combined with phacoemulsification and IOL implantation for PDR. These findings suggest that combined vitrectomy for PDR is a useful surgical procedure.

Entities:  

Mesh:

Year:  2001        PMID: 11195738

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  9 in total

Review 1.  Current management of vitreous hemorrhage due to proliferative diabetic retinopathy.

Authors:  Jaafar El Annan; Petros E Carvounis
Journal:  Int Ophthalmol Clin       Date:  2014

2.  Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.

Authors:  Amod Gupta; Reema Bansal; Vishali Gupta; Mangat R Dogra
Journal:  Int Ophthalmol       Date:  2012-03-27       Impact factor: 2.031

3.  Ahmed valve implantation for neovascular glaucoma after 23-gauge vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Yu Cheng; Xiao-Hong Liu; Xi Shen; Yi-Sheng Zhong
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

4.  Anterior segment complications after phacoemu-lsification combined vitrectomy and foldable intraocular lens implantation.

Authors:  Qin-Xiang Zheng; Rong-Han Wu; Yuan-Ping Zhang; Ming Xu; Wen-Sheng Li
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

5.  Comparison of combined and sequential surgery for proliferative diabetic retinopathy: a single surgeon study.

Authors:  Ye Yang; Jie Zhang; Hong Yan
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

6.  Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.

Authors:  Masashi Sakamoto; Ryuya Hashimoto; Izumi Yoshida; Makoto Ubuka; Takatoshi Maeno
Journal:  Clin Ophthalmol       Date:  2018-11-14

7.  Vitrectomy versus Phaco-vitrectomy.

Authors:  Ahmed Sulaiman Al-Hinai
Journal:  Oman J Ophthalmol       Date:  2019 May-Aug

8.  Effect of Pars Plana Vitrectomy With or Without Cataract Surgery in Patients with Diabetes: A Systematic Review and Meta-Analysis.

Authors:  Kang Xiao; Yi-Chen Dong; Xin-Guang Xiao; Shen-Zhi Liang; Jiong Wang; Cheng Qian; Guang-Ming Wan
Journal:  Diabetes Ther       Date:  2019-07-25       Impact factor: 2.945

9.  Surgical results of combined pars plana vitrectomy and phacoemulsification for vitreous hemorrhage in PDR.

Authors:  Handan Canan; Selçuk Sizmaz; Rana Altan-Yaycioğlu
Journal:  Clin Ophthalmol       Date:  2013-08-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.